Skip to content

Evolutionary Genomics, Inc.: 10-Q filed 2021-08-06

What Evolutionary Genomics, Inc. reported in its quarterly report filed 2021-08-06 (fiscal Q2 2021): 27 published measures, 80 facts as tagged in accession 0001553350-21-000646.

This filing

Form
10-Q (quarterly report)
Filed
2021-08-06
Fiscal period
fiscal Q2 2021
Accession
0001553350-21-000646 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Evolutionary Genomics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-06-303,237,579USD
At 2020-12-313,992,699USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-06-302,451,459USD
At 2020-12-312,248,995USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-06-30-2,783,474USD
At 2021-03-31-2,284,702USD
At 2020-12-31-1,825,890USD
At 2020-06-30-760,480USD
At 2020-03-31-520,611USD
At 2019-12-31-333,725USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-06-30588USD
At 2020-12-31215,836USD
At 2020-06-302,451USD
At 2019-12-3145,441USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-553,701USD91
2021-01-01 to 2021-06-30-1,067,443USD181
2020-04-01 to 2020-06-30-294,798USD91
2020-01-01 to 2020-06-30-536,614USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-06-30-291,643USD181
2020-01-01 to 2020-06-30-267,258USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-01-01 to 2020-06-3012,500USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-06-3076,395USD181
2020-01-01 to 2020-06-30224,268USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-06-30-16,150,995USD
At 2020-12-31-15,083,552USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-06-3034,730USD
At 2020-12-3150,763USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-04-01 to 2021-06-3054,929USD91
2021-01-01 to 2021-06-30109,859USD181
2020-04-01 to 2020-06-3054,929USD91
2020-01-01 to 2020-06-30109,859USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-553,707USD91
2021-01-01 to 2021-06-30-1,067,557USD181
2020-04-01 to 2020-06-30-310,597USD91
2020-01-01 to 2020-06-30-540,414USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-06-3041,881USD
At 2020-12-31277,593USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-06-30129,233USD
At 2020-12-313,164USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-06-303,160,968USD
At 2020-12-313,664,343USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-04-01 to 2021-06-30553,707USD91
2021-01-01 to 2021-06-301,067,557USD181
2020-04-01 to 2020-06-30310,597USD91
2020-01-01 to 2020-06-30552,914USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-04-01 to 2021-06-30136,199USD91
2021-01-01 to 2021-06-30233,014USD181
2020-04-01 to 2020-06-30167,526USD91
2020-01-01 to 2020-06-30260,748USD182

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-06-30503,665USD
At 2020-12-31503,665USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-06-30468,935USD
At 2020-12-31452,902USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-553,701USD91
2021-01-01 to 2021-06-30-1,067,443USD181
2020-04-01 to 2020-06-30-294,798USD91
2020-01-01 to 2020-06-30-536,614USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-553,701USD91
2021-01-01 to 2021-03-31-513,742USD90
2020-04-01 to 2020-06-30-294,798USD91
2020-01-01 to 2020-03-31-241,816USD91

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-625,093USD91
2021-01-01 to 2021-06-30-1,210,227USD181
2020-04-01 to 2020-06-30-366,190USD91
2020-01-01 to 2020-06-30-679,397USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-04-01 to 2021-06-30325,079USD91
2021-01-01 to 2021-06-30649,684USD181
2020-04-01 to 2020-06-3049,842USD91
2020-01-01 to 2020-06-30106,507USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-04-01 to 2021-06-308,017USD91
2021-01-01 to 2021-06-3016,033USD181
2020-04-01 to 2020-06-309,531USD91
2020-01-01 to 2020-06-3019,060USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-06-30519,408USD181
2020-01-01 to 2020-06-3020,361USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-04-01 to 2021-06-306USD91
2021-01-01 to 2021-06-30114USD181
2020-04-01 to 2020-06-3015,799USD91
2020-01-01 to 2020-06-303,800USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-6,845USD182

Inspect the source

Entity
Evolutionary Genomics, Inc. / CIK 0000884363
Captured
SEC response SHA-256
a2b66772c1d0ab2271c82d2191d0de1fc92fc9df77b277aa7e747ea7abf31177

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000884363.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))